
Heartland Family Service
Omaha, Nebraska

Siena Francis House Miracles Treatment
Omaha, Nebraska

Spence Counseling Center
Omaha, Nebraska
No centers match
Try a different search term
3 SAMHSA-listed treatment centers in Omaha, Nebraska. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.

Omaha, Nebraska

Omaha, Nebraska

Omaha, Nebraska
Try a different search term
Omaha, Nebraska has 3 SAMHSA-verified addiction treatment centers offering a range of evidence-based programs. Substance use disorders affect millions of Americans, and access to quality, evidence-based treatment is critical to recovery.
Available programs in Omaha include 2 residential/inpatient rehab programs, 2 outpatient programs, 3 dual diagnosis (co-occurring mental health) programs. All listed facilities are sourced directly from the federal SAMHSA National Registry of Substance Abuse Treatment Services.
Most treatment centers in Omaha accept Medicaid, Medicare, and major private insurance plans including Aetna, Cigna, BlueCross BlueShield, and UnitedHealthcare. Under the Affordable Care Act (ACA) and the Mental Health Parity Act, insurance providers are required to cover substance use disorder treatment at the same level as other medical conditions. Call (319) 271-2077 for a free insurance verification — no obligation, completely confidential.
When selecting from the 3 treatment options in Omaha, consider: the type and severity of the substance use disorder, whether co-occurring mental health conditions require dual diagnosis treatment, your insurance coverage and financial situation, the distance from home and your support network, and the facility's accreditation and evidence-based approach. Our helpline is available 24/7 at (319) 271-2077 to help match you with the right program — free and confidential.
Free, confidential assistance matching you with the right program in Omaha.
Treatment centers in Omaha accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
Cost expectations for Omaha residential addiction treatment span a wide range: standard 30-day residential at facilities accepting most commercial insurance often runs $10,000-$30,000 in pre-insurance billing; premium or specialty programs (luxury, executive, specialized clinical focus) can run $30,000-$70,000+. With in-network commercial insurance, patient out-of-pocket typically lands at the plan's annual out-of-pocket maximum, often $7,000-$10,000 for an individual. Medicaid-covered treatment generally has no direct patient cost beyond modest copays where applicable.
Withdrawal severity is the first clinical screening factor for treatment entry in Omaha. Patients showing or at risk for moderate-to-severe alcohol or benzodiazepine withdrawal typically require medically managed detox before transitioning to lower-intensity care — untreated severe alcohol withdrawal carries 5% mortality and severe benzodiazepine withdrawal can be fatal. Opioid use patients face a different pathway: detox-only is rarely effective for opioid use disorder, and evidence-based protocols typically initiate medication-assisted treatment (buprenorphine or methadone) during the stabilization phase.
Recovery coaching is an emerging aftercare modality in Omaha and broadly across the U.S. Recovery coaches — typically people in long-term recovery, trained and credentialed through state-recognized programs — provide individualized recovery support outside the clinical framework. Functions include navigation of community resources, accountability, advocacy, and peer support. Some Medicaid programs in Nebraska now reimburse for recovery-coach services, expanding access for patients without commercial insurance.
Attention-deficit/hyperactivity disorder (ADHD) in Omaha treatment patients raises specific clinical questions: ADHD medication continuation (stimulant medications can be appropriate even in addiction-recovery contexts but require careful prescribing), evaluation of whether substance use was self-medication for untreated ADHD, and behavioral interventions for executive-function deficits that complicate early-recovery tasks like appointment-keeping, financial management, and structured-day adherence. Adult ADHD remains under-diagnosed in addiction-treatment populations.
Same-day or rapid admission to Omaha programs is most often possible at facilities with rolling intake capacity, particularly during weekday business hours. Weekend admissions are increasingly common but require advance arrangement. Emergency department presentation with active overdose or severe withdrawal sometimes serves as a bridge to Omaha treatment entry — hospital case managers can coordinate transfer to residential treatment directly from ED, particularly for patients with insurance that covers acute stabilization plus subsequent residential.
Adolescents in Omaha access addiction treatment through pathways distinct from adult care: school-based counselor referrals, pediatrician referrals, juvenile justice system connections, and family-initiated admissions. The federally funded Adolescent Community Reinforcement Approach (A-CRA), Multidimensional Family Therapy (MDFT), and structured family-based interventions are first-line evidence-based options. Adult treatment settings are clinically inappropriate for adolescents and most Nebraska jurisdictions require age-appropriate licensed providers.
The decision to enter addiction treatment in Omaha, Nebraska, often follows a precipitating event — an overdose, a medical complication, a legal consequence, a family ultimatum, a job loss, or simply an internal recognition that the substance use has become unmanageable. Whatever the trigger, the next step is usually an admissions call. Admissions counselors in Omaha programs are trained to handle these conversations with people in active substance use, often experiencing shame and ambivalence, and to convert uncertain inquiries into safe transitions into clinical care.